Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Firebrick Pharma Limited ( (AU:FRE) ) has shared an announcement.
Firebrick Pharma Limited announced the issuance of 1,372,618 unlisted options, set to expire on July 4, 2028, at an exercise price of $0.095. This issuance is part of a previously announced transaction and is not intended to be quoted on the ASX, potentially impacting the company’s financial strategy and stakeholder interests.
More about Firebrick Pharma Limited
Firebrick Pharma Limited operates in the pharmaceutical industry, focusing on the development and commercialization of innovative healthcare solutions.
Average Trading Volume: 66,282
Technical Sentiment Signal: Sell
For detailed information about FRE stock, go to TipRanks’ Stock Analysis page.